doesn't add up? LOL, SCAMOOOOOORAMOOOOOOOOOOOOOO that's why

SEE IBOX

Now for CLGZF, which we alerted to you last night, it didn’t get the momentum at the open that we were hoping for to propel it into a breakout. Looks like we had some profit takers from yesterdays trading session get out early and pretty much destroy any chance for a run up.


This is from their main promoters and trust me,it's not profit taking, it's the debt conversion holder...Stay tune sun sentinel article coming soon exposing some interesting items

NFL DEAL??

no floater?

Nice find

NICE NEWS

WOWWWWWWWWWWWWWOOOOOOOOOOOOOOOOW, CHECK THIS OUT

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88500498

Ex-Microsoft Exec to Create First National Marijuana Brand
Text Size Published: Thursday, 30 May 2013 | 3:25 PM ET
Twitter
38
LinkedIn
1
Share

http://www.cnbc.com/id/100777638

Getty Images A former corporate strategy manager at Microsoft plans to create the first national marijuana brand, and said he is kicking off his Seattle-based business by acquiring medical cannabis dispensaries in three states.

Jamen Shively, 45, envisions his enterprise becoming the leader in both recreational and medical cannabis—much like Starbucks is in coffee, he said.

Shively, who was with Microsoft six years and left in 2009, said he was soliciting investors for $10 million in start-up money.

(Read More: The 16 Top Medical Marijuana Strains)

The use, sale and possession of marijuana remains illegal in the U.S. under federal law. But two states have legalized recreational marijuana use and are among 18 states that allow it for medical use. Washington and Colorado became the first states to allow recreational marijuana when voters approved legalization in November.

"It's a giant market in search of a brand," Shively said of the marijuana industry. "We would be happy if we get 40 percent of it worldwide."

The sale of marijuana remains illegal in much of the world, although some countries—mainly in Europe and the Americas—have decriminalized its possession in small quantities. A larger number have decriminalized or legalized marijuana for medical use.

Play VideoLegal Pot! Craving for Cannabis Cash
Brendan Kennedy of Privateer Holdings discusses why he believes the legalization of marijuana presents a big investment opportunity, and how he plans to profit by getting in on the ground level.A 2005 United Nations report estimated the value of the global marijuana trade at $142 billion.


Shively acknowledges that his business plans conflict with federal law and are complicated by regulations in Washington and Colorado. He said he is interested in buying dispensaries that comply with local and state rules and are less likely to attract the scrutiny of authorities.

"If they want to come talk to me, I'll be delighted to meet with them," he said of federal officials. "I'll tell them everything that we're doing and show them all our books."

Washington's marijuana consultant, Mark Kleiman, said he was skeptical.

"It's very hard for me to understand why anybody seriously interested in being in the marijuana business, which after all is against the federal law, would so publicly announce his conspiracy to break that law," said Kleiman, a professor of public policy at the University of California, Los Angeles.

(Read More: Moldy Marijuana)

Emily Langlie, spokeswoman for the U.S. Attorney's Office in Seattle, referred questions to the Department of Justice headquarters. Officials there did not immediately return calls seeking comment.

Rep. Reuven Carlyle, a Seattle Democrat, sees promise in Shively's initiative. Any industry emerging from the shadows will inevitably undergo consolidation—and thereby simplify the task of regulators, he said.

"The fact that an entrepreneur is publicly pushing the envelope around a branding and value-based pricing opportunity, I would say that's in the water in Seattle," said Carlyle, chairman of the House Finance Committee. "That's in our DNA. ... We could have predicted that as much as the rain."

(Read More: Marijuana Investors)

Shively said that he has acquired the rights to the Northwest Patient Resource Center, a medical marijuana operation that includes two Seattle storefronts, that he is close to buying a dispensary in Colorado, as well as two each in Washington and California, with the owners given the option to retain a stake.

"We've created the first risk-mitigated vehicles for investing directly in this business opportunity," he said.

The ultimate plan is for separate medical- and recreational-use brands, Shively said, adding that he also intends to launch a study of the effectiveness of concentrated cannabis oil in the treatment of cancer and other illnesses.

Twitter
38
LinkedIn
1
Share


Print

CRASHING REEEEEEEEEEAAAAAAAAAAAAAAAAAAL HARD. LMAO..WHAT A JOKE ON THAT NEWS. LOLLLLLLLLLLLLLL

SHORT THIS POS DOWN TO 0000000000000000000000000000000000000000

CLGZF - NEWS - PROMO - NO VOL - STOCK FREE FALLING - SCAMMO..NICE

what's going on here? WOW

She's going soar this am

They have a lot of juice these PSYCHO DUDES

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88441218


WOW

www.PennyStockAlerts.com does its best to bring you accurate information but errors may and sometimes do occur. Always do your own research before investing. PennyStockAlerts.com is not a licensed financial advisor. This is a paid advertisement, not a solicitation or recommendation to buy or sell securities.







Good morning everyone!



You ready for this Medical Play??



Did you research EDXC last night?



I only scratched the surface of EDXC. Did you research M3Hub?



M3Hub is one of EDXC subsidiaries that operate in the Medical Marijuana Industry.



The m3Hub Technology platform harnesses technology designed to operate within the framework of the law. Businesses that desire to operate within the legal confines of the industry will want to utilize the best overall technology solution. m3Hub and its business partners are purveyors of products for enhancing the health and welfare of patients and clients. Protecting the patient/client is the core value and consideration for all functions of the technology and compliance features of the platform.



M3 Hub is further developing technology and solution alliances with companies proven to have the best scientific processes and highest regard for compliance as it pertains to the patient. The m3Hub operates under the premise that protecting the patient is the key to building a sustainable and high integrity industry.


The m3Hub platform manages patient concentric data and incorporates best patient privacy practices, the HiTech Act (Health Information Technology for Economic and Clinical Health Act), and patient care services. Through verification, privacy, legal and transparent controls, the m3Hub platform will help legitimize the entire transaction process on behalf of the patient.



The medical cannabis industry alone was worth about $1.7 billion in 2011, according to a report by the financial news firm See Change Strategy. That figure could reach nearly $9 Billion nationwide in five years, as more states are likely to legalize marijuana for medicinal purposes. 18 States have approved it so far. 11 have pending legislation for approval. 4 states have pending legislation favorable to medical marijuana and only 5 states have denied it. This is an incredible sector and EDXC is sitting on the front lines!



There is even more to EDXC than that, you have to research this one to see it all.




EDXC and the company’s subsidiaries hold enormous potential. If you look at the chart below you can see a slow and steady rise in PPS over the past 6 months.


http://www.otcmarkets.com/stock/EDXC/chart




Watch out for gaps today, but watch EDXC very close.



A LOT of people are talking about EDXC after last night's news, and I believe if it trades well it could once again be the BIGGEST stock of the day. Watch it close and be ready for what could be the NEW hot medical marijuana play!





PSA - Stock Psycho





www.pennystockalerts.com





Don’t ever invest based on what I say. Do your own research and consult with a licensed professional before investing, only invest what you are prepared to lose. Any statements and opinions given are amateur and biased and should be treated as such. Past performance does not indicate future performance in any way. The performance of all alerts uncompensated and compensated in no way predict the performance of current and/or upcoming alerts. Check the latest SEC filings before investing, and research other information on the risks of investing in microcap companies at www.sec.gov





READ IMPORTANT DISCLAIMER

Disclaimer – This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by Focus Media. Any reference to “we” or “our” refers to Focus Media. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore unqualified to give investment recommendations. Always do your own research and consult with an licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.


We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on EOD or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices.



We have been compensated seventy thousand dollars cash via bank wire to conduct investor relations advertising and marketing for EDXC by a third party, StockMister LLC. We have not been compensated to alert any of the other companies mentioned in this communication. This compensation is a major conflict of interest in our ability to be unbiased regarding EDXC. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the third party or parties. The third party, profiled company, or affiliates of either, has likely hired Focus Media because the party would like to liquidate a large amount of shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. At times, before we begin our advertising the hiring third party or their affiliate may receive a moderate referral fee from our compensation payment. Focus Media’s business model is to receive financial compensation to promote public companies. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forword looking statements, which are not guaranteed to materialize due to a variety of factors.



We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, Focus Media often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice. See full disclaimer at www.pennystockalerts.com/disclaimer




Focus Media | 331 W 57th Street | New York, NY 10019

Email Marketing by iContact - Try It Free!


Unsubscribe | Forward To a Friend

Members, its important to ADD us to your Email Contact List so you can beat the crowd and get our Awesome Picks sent directly to your Inbox. You can unsubscribe below at any time but you will not get our Awesome Picks and therefore miss Our Next Pick that looks to Run High.


Top Biotech Play & Sub Penny Pick is: ITNS (trading at only .0037 cents)

ITNS could be the Next Blockbuster Biotech Play with Super Upside potential trading at ONLY .0037 cents. Act fast members because we are known for showing super home run moves on Biotech plays and ITNS looks to be a Super Home run play from these low levels.

ITNS, a holding company with divisions in key verticals, including pharmaceuticals, industrials, and technology. The crown jewel in the ITNS family is Itonis Pharmaceuticals, which is developing what may be the first over-the-counter, systemically active preparation delivered via a nasal and/or sublingual spray for the alleviation of mild to moderate nausea. The size of this market is an estimated $1 BB annually.

ITNS (Itonis Pharmaceuticals) is led by Dr. Charles Hensley, the famed homeopathic and nutraceutical pioneer and a founder of the Firm that launched the popular Zicam® Cold Remedy.

IMPORTANT READ: "Dr. Charles Hensley's product development innovation and marketing savvy helped make Zicam® a household name and transformed how homeopathic drugs are marketed and sold in the U.S... Dr. Hensley and his team plan to use the same methodologies to revolutionize the treatment of anti-nausea, as well as other common ailments and chronic diseases, including HIV. This division's mission is to create and market over-the-counter and prescription homeopathic products that better people's lives. Given the advantages of the anti-nausea offering and the leadership's history of success, Itonis Pharmaceuticals could be a major player in the homeopathic and nutraceutical arena."

Dr. Hensley is a pioneer in the development and marketing of safe and effective therapeutic nutraceutical and homeopathic preparations. Dr. Hensley was a founder of Geltech, LLC that launched the Zicam® Cold Remedy, making the product a household name and forever changing the marketing and product placement paradigm for homeopathic drugs in the United States. He and his team plan to use the same methodologies to revolutionize the treatments of several other common ailments and other chronic diseases for ITNS.

For more information on Itonis, Inc., please visit www.itonisholdings.com.







ITNS is the New Blockbuster Biotech play that looks to Break Records by Monday. ITNS is our New Sub Penny Biotech pick at .0037 cents. If you recall our last Biotech pick, BMSN, was a blockbuster hit and ran from .0024 to .0165 (588% run) short term.

ITNS looks to make a major move here short term. We believe ITNS is a blockbuster hit down here at .0037 cents (Sub penny levels) and we are hearing some major things are in the pipeline for ITNS. The company has been releasing some Recent Mega News, is trading way undervalued near its 52 week low and the BUZZ is starting to rapidly increase for this Biotech play.





Members - Add Us to your Contact List (Address book) & Safe Sender List now..

Add our sender name AwesomeStockPick and sender email address info@awesomestockpick.com to your contact list (address book) or safe sender list. Add us now to ensure you get our AwesomeStockPick's sent directly to your email inbox and not your spam box. Remember, timing is everything in the markets and that's why its important to add us now.

Your Team,
AwesomeStockPick

GENERAL NOTICE AND DISCLAIMER (Please read carefully): We are engaged in the business of advertising and marketing companies for monetary compensation. By viewing or using AwesomeStockPick.com (hereafter referred to as "ASP") you hereby fully agree to our Legal Disclaimer & Disclosure ( http://awesomestockpick.com/disclaimer) and our Pr ivacy Policy. This is not a solicitation to buy or sell a security. This is for entertainment purposes only. Never invest into a stock discussed on our website or the ASP newsletter unless you can afford to lose your entire investment. ASP is not a registered broker dealer or a registered investment advisor. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. Please consult with a certified financial advisor before making any investment decisions. This is sponsored advertising and does not purport to provide an analysis of the featured company's financial position, operations or prospects and is not to be construed as a recommendation or solicitation by ASP, to buy or sell any security in any jurisdiction. The information contained herein is based on sources that ASP believes to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. ASP encourages readers and investors to supplement the information in this report with independent research and other professional advice. All information on the featured company is provided by the company profiled, or is available from public sources and ASP makes no representations or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this report are statements of judgment as of the date of publication and are subject to change without further notice and may not necessarily be reprinted in future publications or elsewhere. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the company profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead ASP strongly urges you to conduct a complete and independent investigation of the respective companies. ASP does not offer such advice or analysis and ASP further urges you to consult your own independent tax, business, financial and investment advisors. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the company profiled. ASP, its operators, owners, employees, and affiliates may have interests or positions in equity securities of the companies profiled by ASP, some or all of which may have been acquired prior to the dissemination of this report and may increase or decrease these positions at any time. This report may contain forward-looking-statements, which involve risks and uncertainties. Accordingly no assurance can be given that the actual events and results will not be materially different than the anticipated results described in the forward statement. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking-statements made by ASP about the company profiled. If applicable investors are also directed to consider other risks and uncertainties discussed in documents filed by the profiled company with the Securities and Exchange Commission. ASP undertakes no obligation to publicly release the result of any revisions to these forward-looking-statements which may be made to reflect events or circumstances after the date hereof to reflect the occurrence of unanticipated events.

Notice of Stock Price Volatility and Movements: Viewers of this newsletter should understand that trading activity and stock prices in many if not all cases tend to increase during the advertisement campaigns of the profiled companies and in many if not all cases tend to decrease thereafter. This tends to create above average volatility and price movements in the profiled company during the advertisement campaign that viewers should take into consideration at all times. Campaigns vary in length, and many are for short periods of time, typically less than a week.



Third Party Advertising Agency/Advertiser: ASP has not received compensation for this investor communications services on ITNS however ASP does expect to be compensated up to two thousand five hundred usd from a third party non affiliate for coverage on Itonis, Inc. (hereafter referred to as "ITNS"). ASP receives this compensation as a production budget for advertising efforts and will retain amounts over and above the cost of production, copy-writing services, mailing and other distribution expenses as a fee for our services. As such, our opinion is neither unbiased nor independent, and you should consider that when evaluating our statements regarding ITNS. When compensation for a production budget for its marketing and advertising efforts are retained, ASP will disclose any future compensation if such compensation occurs. In future, ASP will disclose any and all further and future compensation. Some of the services performed have or may include profiling the company on the ASP website and issuing opinions concerning this new profile in newsletters. Anyone viewing the ASP website or its newsletters should assume the hiring party or affiliates of the hiring party own shares of ITNS, which they plan to liquidate. Further, it must be understood that the liquidation of those shares may or may not negatively impact the share price. ASP, the third party advertiser, has represented that it is not a current shareholder of ITNS and that it does not buy or sell any shares in ITNS during the period that this advertisement is being disseminated.







AwesomeStockPick.com
364 E Main St #724
Middletown, DE, 19709
United States



--------------------------------------------------------------------------------

www.PennyStockAlerts.com does its best to bring you accurate information but errors may and sometimes do occur. Always do your own research before investing. PennyStockAlerts.com is not a licensed financial advisor. This is a paid advertisement, not a solicitation or recommendation to buy or sell securities.









Good afternoon everyone. Wow what an electrifying day for PRKA.





I alerted PRKA at only .025, just 2 and a half cents. But PRKA went absolutely insane and took off from .025 to a high of .203! From 2 and a half cents to over TWENTY cents for a 712% move.



PRKA opened at .039, which gave TRUE profit potential of up to 420%! The run was faster than last time, but it was even more explosive. Traders were truly doubling their money or more, within minutes!



It was definitely an incredible morning. Thank you for all the emails. I can't believe we had another real triple digit gainer! Especially in today's ice cold market.



Unfortunately eventually today's cold market rode on PRKA and we didn't have a huge close (only up 80%), but it was still a big green day with tons of profit potential.





Can you believe that this was our FIFTH triple digit gainer in a row?



When you're hot, you're hot. Now I want to reward some of you with some things you've been asking for...



Personally, I prefer alerts at the opening bell. That's just me. But many of my readers want some alerts at NIGHT, and I get asked for them non-stop. So everyone once in a while I have to cave in to popular demand, and do an alert at night for those who keep hounding me for it!



This looks to be a good one too.



Specifically, it's in a niche-sector that I've been getting HOUNDED to death by my readers about. Everyone wants a...MEDICAL MARIJUANA play.



So it's Popular Demand Night. It's TGIF and we're all gonna be Urkel.



My new play will be out VERY shortly, just putting the finishing touches on it now. You'll see it AFTER the close just like you want it ;)



Smokin' hot medical marijuana play comin' right up TONIGHT!



The profit potential will be very...high.





PSA - Stock Psycho



www.pennystockalerts.com









Don’t ever invest based on what I say. Do your own research and consult with a licensed professional before investing, only invest what you are prepared to lose. Any statements and opinions given are amateur and biased and should be treated as such. Past performance does not indicate future performance in any way. The performance of all alerts uncompensated and compensated in no way predict the performance of current and/or upcoming alerts. Check the latest SEC filings before investing, and research other information on the risks of investing in microcap companies at www.sec.gov





READ IMPORTANT DISCLAIMER

Disclaimer – This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by Focus Media. Any reference to “we” or “our” refers to Focus Media. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore unqualified to give investment recommendations. Always do your own research and consult with an licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.


We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on EOD or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices.



We have not been compensated for this message. We were not compensated to alert PRKA and we own no position. We were not compensated to alert any of the other companies named in this message, and we own no position in any of them. However, we are frequently compensated cash via bank wire to conduct investor relations marketing for the companies we profile and alert, by third parties or the companies directly. Any future profile regarding a specific company will likely be the result of a paid marketing campaign. Check individual disclaimers for compensation details. Focus Media’s business model is to receive financial compensation to promote public companies. All of this compensation is a major conflict of interest in our ability to be unbiased regarding the company(s) discussed in our alerts. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the third party or parties. The third party, profiled company, or affiliates of either likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forword looking statements, which are not guaranteed to materialize due to a variety of factors.



We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, Focus Media often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice. See full disclaimer at www.pennystockalerts.com/disclaimer


Focus Media | 331 W 57th Street | New York, NY 10019

Email Marketing by iContact - Try It Free!


Unsubscribe | Forward To a Friend

http://otcshortreport.com/index.php?index=ptog&action=view

Historical Short Selling Data For ptog


OVE 1M SHORT

Date

VolShorted

High

Low

Close

Chg

ShortVol

RegularVol





May 29 36.85% NA NA NA NA 12,000 32,568
May 28 22.97% NA NA NA NA 39,630 172,549
May 24 40.29% NA NA NA NA 130,772 324,556
May 23 34.51% NA NA NA NA 582,453 1,687,998
May 20 27.00% NA NA NA NA 9,278 34,363
May 17 31.04% NA NA NA NA 3,000 9,664
May 16 67.11% NA NA NA NA 110,989 165,382
May 13 86.01% NA NA NA NA 2,459 2,859
May 07 47.01% NA NA NA NA 1,000 2,127

http://www.cnbc.com/id/100736915

Nasdaq Agrees to Pay $10 Million to Settle SEC Charges Over Facebook IPO
Text Size Published: Wednesday, 29 May 2013 | 11:59 AM ET
Twitter
53
LinkedIn
1
Share



Ben Hider | Getty Images The Securities and Exchange Commission slapped the Nasdaq stock exchange with a $10 million fine for alleged securities laws violations resulting from its "poor systems and decision-making" during the Facebook IPO.

This is the largest fine ever levied against an exchange by the SEC.


"Exchanges have an obligation to ensure that their systems, processes, and contingency planning are robust and adequate to manage an IPO without disruption to the market, the SEC said in a statement. "[D]espite widespread anticipation that the Facebook IPO would be among the largest in history with huge numbers of investors participating, a design limitation in Nasdaq's system to match IPO buy and sell orders caused disruptions to the Facebook IPO. Nasdaq then made a series of ill-fated decisions that led to the rules violations."


(Read More: Time to 'Defriend' Facebook?)

Nasdaq agreed to pay the fine without admitting or denying the allegations — and without further apology.


"The settlement is another important step forward and follows the commission's approval in April of our plan to accommodate investors," Nasdaq OMX CEO Robert Greifeld said in a statement. "In the last year, we have carefully reviewed these events. As market leaders, we view our experiences as opportunities to learn and improve. As part of our commitment to continually improve, we have met with many market participants, engaged leading consultants, and closely examined the way we execute initial public offerings."

A few weeks after the botched IPO, Greifeld appeared on CNBC and apologized to investors.


"We have been embarrassed and certainly we apologize to the industry," Greifeld said. (Watch the interview.)

Facebook's IPO on May 18, 2012 was marred by technical glitches that left the market makers — who facilitate trades for brokers and are crucial to the smooth operation of stock trading — in the dark for hours as to which trades had gone through.

Nasdaq said it "tested extensively" its systems before the IPO but the testing did not reveal the "design flaw" that caused the glitches.

The SEC said several members of Nasdaq's senior leadership team convened a "Code Blue" conference call, at the SEC's request, and opted to not delay the start of secondary market trading in shares of Facebook, thinking they had fixed the problem by removing a few lines of code.


But they didn't understand the root cause of the problem, the SEC said. The decision to resume trading without fully understanding the problem resulted in violations of several rules, according to the SEC, including Nasdaq's own rule governing the price/time priority for executing trade orders.

Trading was delayed until 11:30 am the day of the IPO. Confirmation of the initial trades didn't post until 1:50 pm. That left more than 30,000 Facebook orders to remain stuck in the Nasdaq's system for more than two hours when they should have been promptly executed or canceled, the SEC said.


(Read More: The 10 Biggest Internet IPOs)

The SEC also cited the fact that Nasdaq broke its own rules when it assumed a short position, betting that a stock will fall, of more than three million Facebook shares in an "unauthorized error account." Nasdaq then covered that short position for about $10.8 million, which also violated Nasdaq's own rules. It also cited three other violations of Nasdaq's own rules during the opening of trading.

The SEC also charged Nasdaq's affiliated third party broker-dealer, Nasdaq Execution Services, with failing to maintain sufficient net capital reserves on the day of the Facebook IPO as a result of that big short position in the unauthorized account.

"This action against Nasdaq tells the tale of how poorly designed systems and hasty decision-making not only disrupted one of the largest IPOs in history, but produced serious and pervasive violations of fundamental rules governing our markets," George S. Canellos, co-director of the SEC's Division of Enforcement, said in a statement.


This fine is in addition to the millions that Nasdaq has already agreed to pay to trading firms that suffered losses during the IPO.


Greifeld said Nasdaq has taken additional steps to ensure the safety of its trading platform, including changing its procedure for "the cross," which is matching buy and sell orders, and deploying new global processes for changing technology. It has also created two new positions, chief information officer and global head of market systems, as well as an engineering team dedicated to monitoring and analyzing daily system performance and a quality assurance organization focused on testing the trading systems.

"We recognize that the cornerstone of a market is investor confidence," Greifeld said.

Click here for the latest on the markets.

give it a few weeks, I am

shorts do not have to cover on this scam

then trips

yup but the bird lives in montreal

party over soon.. little Canadian bridie told me

gm

I am holding my position that I owned before the RS split..My average is 0001 which is roughly two and half cents as of today so I am up 4 times my $$$$$$$$$ right now.

THEN TELL HERBERT AND BOBBY TO GET SOME EQUIPMENT AND START DIVING SOMEWHERE.



not happening

complete scam, has been since inception

complete disaster so far but we will see. I have been through worse

I would personally hold it for a few weeks until PTOG proves itself and starts getting oil out of the ground. I am in a wait and see mode..What a joke the stock price has been..The bashers and shorters are winning right now but I will wait it out

http://otcshortreport.com/index.php?index=ptog&action=view

Historical Short Selling Data For ptog

TRY 1M SHORT with 3.8M in float

Date

VolShorted

High

Low

Close

Chg

ShortVol

RegularVol





May 24 40.29% NA NA NA NA 130,772 324,556
May 23 34.51% NA NA NA NA 582,453 1,687,998
May 20 27.00% NA NA NA NA 9,278 34,363
May 17 31.04% NA NA NA NA 3,000 9,664
May 16 67.11% NA NA NA NA 110,989 165,382
May 13 86.01% NA NA NA NA 2,459 2,859
May 07 47.01% NA NA NA NA 1,000 2,127

it's a battle between the shorts and longs. shorts on the right, longs on the left

http://blogs.scientificamerican.com/tetrapod-zoology/files/2013/02/Johan-Opperman-Kruger-crocodile-attacks-baby-elephant-600-px-tiny-Feb-2013.jpg

HUGE, Listen carefully

http://video.cnbc.com/gallery/?play=1&video=3000170586

IMO PTOG is on to the same thing in a smaller way

LMAO. But some bite harder than others

HUGE, Listen carefully

http://video.cnbc.com/gallery/?play=1&video=3000170586

IMO PTOG is on to the same thing in a smaller way

Play Video Chevron's New Technology
Getting oil out of the ground has become increasingly controversial, with CNBC's Jane Wells


http://www.cnbc.com/id/100765346

1,000,000 shares
short on a company that only has 3.8M???


http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88334291

Let's see what happens @ the open

The Following is a Paid for Advertisement and not a solicitation or recommendation to buy or sell securities. Epicstockpicks.com
is not a licensed financial advisor and does its best to bring you accurate information but errors may and sometimes do occur.





THE NEW EPIC BOTTOM BOUNCER PICK IS
TENP (Technologies Scan Corp)!




Hello Traders,

TENP (Technologies Scan Corp) is our New Epic Pick!
Last Trade: .057 SEC Filings. Recent News

Begin your research at www.techno-scan.com


Many of our long-time subscribers know one thing...when we "Call the Bounce", the Street listens!

Tonight we take a departure from our usual "Opening Bell Alerts" because we want you to truly check out and research a fresh new company with substantial "BOUNCE" potential...TENP.

TENP is a development stage company that operates in the Health Products industry with "tech" twist. With the company's mobile software, TENP aims to change how we obtain nutritional information forever! But thats just the beginning! In some very recent developments, TENP has acquired the rights to sell a popular weight-loss product, effectively entering a market which represents $66 BIL in annual sales!

The company has recently hinted at potential future ACQUISITION NEWS which could be a game-changer for the company and investors alike!

But before we get into all of that...why on Earth did TENP plummet so quickly??


TENP - ON THE VERGE OF AN EPIC "BOUNCE OFF THE BOTTOM"?
It's no secret that TENP got hit hard last week. In it's first week of trading actively, it saw highs of .243 before plummetting two days later to the current price of .057. This was especially interesting as the company had been very newsworthy in the last week.

So what caused such a drop?
While we may never know exactly why TENP declined last week, many times these situations can be attributed to naked-short selling, insiders, and dilution which eventually causes "panic selling" by investors. The result is a mass sell-off that may fall too quickly. Often times, after a mass sell-off occurs, we see a Technical Bounce.

So what is a BOTTOM BOUNCE?
A temporary or full recovery/reversal from a prolonged decline or bear market. A bounce
could be a small, short-lived recovery in the price of a declining security or signal a full
reversal of the price. Frequently, downtrends are interrupted by brief periods of recovery
- or small rallies - where prices temporarily rise. This can be a result of traders or investors
closing out short positions or buying on the assumption that the security has reached a bottom.

Keep in mind that if TENP were to see a Bounce off of current prices back to previous highs, the result would be an extraordinary 326% GAIN!

With the potential for future acquisition news on the way, could TENP become our most Epic BOTTOM BOUNCER of all time? Check out the chart below...



So who is TENP and what is this potential Acquisition News we keep referring to?


TENP - DIVERSIFYING IN TODAY'S HEALTH INDUSTRY
Technologies Scan Corp is a development stage company whose plan of operation is selling and distributing health products, including a health database system. The company has developed an exhaustive database and software for natural health products and believes thier Medicus21software is a unique information provider of natural health products to be used through a mobile application and barcode reader.

Medicus21 enables the user to scan any natural health product’s bar code, through the help of their smart phone, and instantly obtain all nutritional information, use, benefits and a plethora of information on the product.




But TENP has proven it can diversify itself the multi-billion dollar health industry...

On May 21st, TENP announced a joint venture with Social Geek Media for the exclusive commercialization of Proteina21 for the US Market. The company's Joint Venture with SGM includes the design, technologies, how to, development, production and sale of nutritional, protein and dietary supplements online.

This announcement is an absolute game-changer for TENP as it could immediately provide substantial revenue for the company!

What is Proteina21?
Proteina21 is a weight loss product already sold in Canada and is one of the fastest growing product lines of Social Geek Media, a company specializing in online marketing and distribution.

Proteina21's product line of food supplements and ready-made high in protein and low in carbohydrates is designed to help people lose weight. The products are shipped overnight and are available through online sales via the company's website at www.proteina21.com

All Proteina21 products have common features, including:

1) A flavor, taste and format tailored to market needs;
2) Quick and easy preparation;
3) Scientific formulation;
4) Rigorous manufacturing standards.




According to the company's news release, Proteina21 had sales over $500,000. in the first quarter in just the Canadian market alone!

"The US market is 10 times larger than the Canadian market, and if we judge by the
results of the sales in the Canadian market, we will become a strong competitor in
the space of weight loss" said Gilbert Pomerleau, Vice-President of TENP


COULD POTENTIAL ACQUISITION NEWS PROPEL TENP TO NEW HEIGHTS?
When it comes to the market, sometimes it doesn't necessarily matter what the company is doing now - but what they plan to do and how they plan to show growth.

For example, take a look at Apple - the company has been doing phenomenal for years - yet their share price continues to fall because the Street no longer sees growth potential.

Fortunately, TENP may have that covered as the company has eluded to two major potential acquisitions with regards to Proteina21!

Last Wednesday, May 22, the company announced that they are currently in negotiations with Social Geek Media for an option on the outright acquisition of an exclusive license of Proteina21 in the Canadian market. As we mentioned, the company already claims sales of over $500k in this market!

But thats not all...just this Friday, May 24th, TENP announced they are also in negotiations for the European market!


THE BOTTOM LINE
This potential Acquisition News could be tremendous for the company and traders alike and we'll be keeping a close eye on the news wires. If all came to plan, TENP would effectively control all sales in the US, Canada, and Europe - presenting a substantial revenue opportunity!

With so much to look forward to with TENP, could we finally see an end to it's recent decline with a major BOUNCE OFF THE BOTTOM?

Make sure TENP is on your screen Tomorrow Morning and enjoy the early alert!


Good Trading,
Epicstockpicks.com





GO VIP for a Limted Time Only! Read More...


Disclaimer: http://www.epicstockpicks.com/disclaimer
This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. PLEASE NOTE WELL: Epicstockpicks.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. EPICSTOCKPICKS.COM WILL NEVER ACCEPT FREE OR RESTRICTED TRADING SHARES IN ANY COMPANIES MENTIONED at EPICSTOCKPICKS.COM &/OR ANY OF OUR SOCIAL NETWORKING AND EMAIL ADVERTISING PLATFORMS. Our website and newsletter are for entertainment purposes only. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Gains mentioned in our newsletter and on our website may be based on End of Day or intraday data. The disclaimer is to be read and fully understood before using our site, or joining our email list. Full disclaimer can be read at http://www.epicstockpicks.com/disclaimer

Release of Liability: Through use of this email and/or website advertisement viewing or using you agree to hold Epicstockpicks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Epicstockpicks.com sponsored advertisements do not purport to provide an analysis of any company's financial position, operations or prospects and this is not to be construed as a recommendation by Epicstockpicks.com or an offer or solicitation to buy or sell any security. Compensation: Epicstockpicks.com has been compensated twenty-five thousand dollars cash via bank wire by a third party, RJLQ Investments S.A. for a one day Technologies Scan Corp. advertising services contract. Epicstockpicks.com does not own any shares of TENP. Epicstockpicks.com does not investigate the background of any third party. The third party may have shares and may liquidate it, which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Epicstockpicks.com may purchase shares on the open market of any mentioned company following the dissemination of this email. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Epicstockpicks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is collected from public sources only such as the profiled company's website, news releases, and corporate filings, but has not been verified in any way to ensure the publicly available information is correct. Epicstockpicks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Further, Epicstockpicks.com has no advance knowledge of any future events of the profiled companies which includes, but is not limited to, news press releases, changes in corporate structure, or changes in share structure.

None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead Epicstockpicks.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. Epicstockpicks.com is compliant with the Can Spam Act of 2003. Epicstockpicks.com does not offer such advice or analysis, and Epicstockpicks.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled.

The Private Securities Litigation Reform Act of 1995 provides investors a 'safe harbor' in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results.

In preparing this publication, Epicstockpicks.com has relied upon information supplied by various public sources and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this email and website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. Epicstockpicks.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. Epicstockpicks.com is not responsible for any claims made by the companies advertised herein, nor is Epicstockpicks.com responsible for any other promotional firm, its program or its structure.







MFG LLC | 40 Wall St | New York, NY 10005

Email Marketing by iContact - Try It Free!


Manage Your Subscription | Forward To a Friend

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88334291